NCT06989437: A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 982 planned
- Started
- 3 Oct 2025
- Primary completion
- 23 Jan 2028
- Arms
- Double-Blind ponsegromab Treatment lower dose, Double-Blind ponsegromab Treatment higher dose
- Results
- None posted
- 25 May 2025: Trial registered
- 3 Oct 2025: Trial started